- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07640958
Effects of an 8-week Plyometric Training Programme on Sprint, Jump, and Agility Performance in Recreational Male Football Players Aged 14-16 Years
8 juin 2026 mis à jour par: Ferhat KILIÇARSLAN, TC Erciyes University
Effects of an 8-week Plyometric Training Programme on Sprint, Jump, and Agility Performance in Recreational Male Football Players Aged 14-16 Years: a Randomized Controlled Trial
This study examined the effects of an 8-week plyometric training programme on jump, sprint, and agility-related performance in recreational male football players aged 14-16 years.
This study examined the effects of an 8-week plyometric training programme on jump, sprint, and agility-related performance in recreational male football players aged 14-16 years.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
This study examined the effects of an 8-week plyometric training programme on jump, sprint, and agility-related performance in recreational male football players aged 14-16 years.
This study examined the effects of an 8-week plyometric training programme on jump, sprint, and agility-related performance in recreational male football players aged 14-16 years.
Type d'étude
Interventionnel
Inscription (Réel)
28
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Ankara, Turquie (Türkiye)
- Gazi University
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
Accepte les volontaires sains
Oui
La description
Inclusion Criteria:
- min 14 years
Exclusion Criteria:
- max 16 years
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Plyometric training plus routine football training
Participants in this arm received an 8-week supervised plyometric training programme in addition to their routine football training.
Outcomes were assessed at baseline and immediately after the 8-week intervention period.
|
A supervised 8-week plyometric exercise programme added to routine football training.
The programme included progressive plyometric exercises designed to improve lower-limb explosive power, sprint performance, jump performance, and agility-related performance in recreational adolescent male football players.
Participants maintained their usual football training programme during the 8-week study period.
This training exposure was continued in both study arms and served as the active comparator condition for the control group.
|
|
Comparateur actif: Routine football training
Participants in this arm continued their routine football training during the same 8-week period and did not receive the additional plyometric training programme.
Outcomes were assessed at baseline and immediately after the 8-week period.
|
Participants maintained their usual football training programme during the 8-week study period.
This training exposure was continued in both study arms and served as the active comparator condition for the control group.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in 30 m sprint time
Délai: Baseline and immediately after the 8-week intervention
|
Sprint performance was assessed using the 30 m sprint test.
Time was recorded in seconds using photocell timing gates.
Lower values indicate better sprint performance.
|
Baseline and immediately after the 8-week intervention
|
|
Change in vertical jump height
Délai: Baseline and immediately after the 8-week intervention
|
Vertical jump performance was assessed using the My Jump 2 application.
Jump height was recorded in centimetres.
Higher values indicate better jump performance.
|
Baseline and immediately after the 8-week intervention
|
|
Change in 505 agility test time
Délai: Baseline and immediately after the 8-week intervention
|
Change-of-direction performance was assessed using the 505 agility test.
Time was recorded in seconds.
Lower values indicate better agility performance.
|
Baseline and immediately after the 8-week intervention
|
|
Change in standing long jump distance
Délai: Baseline and immediately after the 8-week intervention
|
Horizontal jump performance was assessed using the standing long jump test.
Jump distance was recorded in centimetres.
Higher values indicate better horizontal jump performance.
|
Baseline and immediately after the 8-week intervention
|
|
Change in quick feet test time
Délai: Baseline and immediately after the 8-week intervention
|
Footwork performance was assessed using a 10 m ladder-based quick feet test.
Time was recorded in seconds.
Lower values indicate better footwork performance.
|
Baseline and immediately after the 8-week intervention
|
|
Change in zig-zag running test time
Délai: Baseline and immediately after the 8-week intervention
|
Multidirectional running performance was assessed using the zig-zag running test.
Time was recorded in seconds.
Lower values indicate better multidirectional movement performance.
|
Baseline and immediately after the 8-week intervention
|
|
Change in body mass index
Délai: Baseline and immediately after the 8-week intervention
|
Body mass index was calculated from measured body mass and height and reported as kg/m².
|
Baseline and immediately after the 8-week intervention
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
20 janvier 2026
Achèvement primaire (Réel)
31 mars 2026
Achèvement de l'étude (Réel)
31 mars 2026
Dates d'inscription aux études
Première soumission
27 mai 2026
Première soumission répondant aux critères de contrôle qualité
8 juin 2026
Première publication (Réel)
11 juin 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
11 juin 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
8 juin 2026
Dernière vérification
1 mai 2026
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- E-77082166-604.01-1455789
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .